Top 50 Life Science Startup Investors in Germany (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
7 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $994k–$40M |
|
coparion
VC Fund
|
5 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
IFB Innovationsstarter
VC Fund
|
5 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $80k–$3M |
|
Grazia Equity
VC Fund
|
3 | Germany, United States, Switzerland | Series A, Series B, Seed | Internet, E-Commerce, Biotechnology | $1.1M–$59M |
|
Lowercarbon Capital
VC Fund
|
3 | United States, United Kingdom, France | Seed, Series A, Series B | Renewable Energy, Energy, Biotechnology | $3M–$150M |
|
Good Seed Ventures
VC Fund
|
3 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $25k–$21M |
|
Agronomics
VC Fund
|
3 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
Lima Ventures
VC Fund
|
3 | Turkey, United Kingdom, Estonia | Seed, Pre-Seed | Artificial Intelligence, Software, FinTech | $18k–$702k |
|
b.value AG
VC Fund
|
3 | Germany, Poland | Seed, Series A | Biotechnology, Manufacturing, Chemical | $478k–$40M |
|
Elevat3 Capital
VC Fund
|
3 | Germany, United Kingdom | Series A, Series B, Post-IPO Equity | FinTech, Apps, Social | $45M–$157M |
|
CPT Capital
VC Fund
|
3 | United States, Israel, United Kingdom | Series A, Seed, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
Inflection
VC Fund
|
2 | United States, Germany, United Kingdom | Seed, Pre-Seed | Blockchain, Cryptocurrency, Software | $665k–$13M |
|
Holger Hübner
Angel
|
2 | Germany | Seed, Pre-Seed | B2B, SaaS, Audio | $177k–$987k |
|
AQAL Integral Investing
VC Fund
|
2 | Germany, United States | Seed, Pre-Seed | Health Care, Medical Device, Medical | |
|
Ananda Impact Ventures
VC Fund
|
2 | Germany, United Kingdom, Finland | Seed, Series A | Health Care, Software, Information Technology | $1.6M–$17M |
|
Michael Novogratz
Angel
|
2 | United States, India, Germany | Seed, Series A | Blockchain, Cryptocurrency, FinTech | $953k–$38M |
|
1kx
VC Fund
|
2 | United States, Germany, Switzerland | Seed, Series A | Blockchain, Cryptocurrency, Software | $1.8M–$28M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$95M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $125k–$37M |
|
Die Brückenköpfe
VC Fund
|
2 | Germany, Austria | Seed, Series A, Pre-Seed | Health Care, Life Science, Therapeutics | $5.5M–$19M |
|
Albert Wenger
Angel
|
2 | United States, Germany, Switzerland | Series A, Series B, Seed | Software, Manufacturing, Internet | $650k–$38M |
|
Shine Capital
VC Fund
|
2 | United States, Spain, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $3.5M–$71M |
|
IBB Ventures
VC Fund
|
2 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$9M |
|
KfW
VC Fund
|
2 | Germany, India, Spain | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
Happiness Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Food and Beverage, AgTech | $2M–$61M |
|
Zee Prime Capital
VC Fund
|
2 | United States, Singapore, United Kingdom | Seed, Series A | Blockchain, Cryptocurrency, Information Technology | $1.9M–$43M |
|
EQT Group
VC Fund
|
2 | Germany | Series A | Life Science, Biotechnology, Food and Beverage | $46M–$50M |
|
Lionheart Ventures
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A | Health Care, Biotechnology, Wellness | $25k–$46M |
|
Investitionsbank Berlin
VC Fund
|
2 | Germany, Canada | Grant, Seed | Software, Information Technology, Artificial Intelligence | $19k–$2.3M |
|
M Ventures
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Thor Bjorgolfsson
Angel
|
2 | United Kingdom, Germany | Seed, Series A, Series C | Big Data, TV, B2B | $26M–$26M |
|
Nico Wittenborn
Angel
|
2 | United States, Germany, France | Seed, Series A, Series B | Software, Apps, Wellness | $1.6M–$88M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$20M |
|
KdT Ventures
VC Fund
|
1 | United States, Israel, Germany | Seed, Series A, Series B | Biotechnology, Health Care, Medical | |
|
TechVision Fund
VC Fund
|
1 | Germany, Spain | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | |
|
NAP
VC Fund
|
1 | Germany | Pre-Seed | Software, Health Care, Life Science | |
|
Boost VC
VC Fund
|
1 | United States, Canada, United Kingdom | Seed, Pre-Seed | Software, Virtual Reality, Blockchain | |
|
Till Knorr
Angel
|
1 | Germany | Seed | Health Care, Life Science, Biotechnology | |
|
Indiana Capital
VC Fund
|
1 | Germany | Seed | News, Life Science, Social Media | |
|
Nikolaus Sturm
Angel
|
1 | Germany | Seed | Life Science, Biotechnology | |
|
German Federal Ministry of Education and Research
VC Fund
|
1 | Germany, United States, Denmark | Grant, Seed, Series B | Biotechnology, Medical, Health Care | |
|
Boom Capital Ventures
VC Fund
|
1 | United States, Canada, France | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | |
|
Acurio Ventures
VC Fund
|
1 | Spain, United States, Germany | Seed, Series A, Series B | Software, E-Commerce, Internet | |
|
Brightlands Venture Partners
VC Fund
|
1 | The Netherlands, Germany | Seed, Series A | Biotechnology, Medical Device, Health Care | |
|
Qiagen
VC Fund
|
1 | Germany, United States | Seed, Series B | Biotechnology, Medical, Biopharma | |
|
Wille Finance
VC Fund
|
1 | Germany, Switzerland, France | Seed, Series A, Series C | Health Care, Biotechnology, SaaS | |
|
Teknoloji Yatirim
VC Fund
|
1 | Turkey, United States, Germany | Seed, Series A, Convertible Note | Software, Machine Learning, Analytics | |
|
Pillar VC
VC Fund
|
1 | United States, Spain, Israel | Seed, Series A | Software, Biotechnology, Health Care | |
| Access all 250 investors in Germany Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 556
- Round size: Seed $994k–$7.4M; Series A $3M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Phytonics — Phytonics offers a broadband and omnidirectional anti-reflective and light trapping coating for photovoltaics. Twice the yield of standard anti-reflective coatings and superior aesthetics. Inspired by Evolution.
- Mosanna Therapeutics — Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 80
- Round size: Seed $658k–$3M; Grant $80k–$165k
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more...Investment focus
- Industry: Internet, E-Commerce, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 83
- Round size: Seed $1.1M–$8M; Series A $1.1M–$53M; Series B $4M–$59M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- GYANT — Create more capacity to care. Fabric is the care enablement system powering healthcare to move faster, work smarter, and deliver better care.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Mister Spex — Mister Spex is an online store that sells various brands of glasses and contact lenses in Germany. Its product range includes over 5000 different glasses, sunglasses, sports eyewear, and contact lenses from more than 60 brands and designers.The store’s offerings include sports labels such as Adidas, Carrera, Lacoste, and Oakley to designer brandssuch as Burberry, Calvin Klein, Dolce&Gabbana, Gucci, Jil Sander, Prada, Roberto Cavalli, Tom Ford, and Versace.Mister Spex was launched in 2007 and its operations are headquartered in Berlin, Germany. It also operates its own websites in France, Spain, Austria, Switzerland, the Netherlands, and Great Britain.
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 189
- Round size: Seed $3M–$12M; Series A $11M–$50M; Series B $21M–$150M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- Flair — Smart climate control in every room. Wireless smart thermostats and Smart Vents for Central Heating & AC, Mini Splits, Window ACs, Nest, Ecobee, and more
- Quilt — Quilt is the best home climate system available. Our electric, energy efficient heat pump uses smart technology to save homeowners money and cut emissions.
- Zap Energy — Zap Energy's fusion reactor stabilizes plasma using sheared flows rather than magnetic fields. Driving electric current through the flow creates the magnetic field, which confines and compresses the plasma. The higher the current, the greater the pressure and density in the plasma. Zap Energy's reactor is the least expensive, mostcompact, most scalable solution with the shortest path to commercially viable fusion.
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 31
- Round size: Seed $25k–$7M; Series A $6.7M–$21M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 46
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
- Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed
- Geography: Turkey, United Kingdom, Estonia
Investor stats
- Total investments: 32
- Round size: Seed $18k–$702k
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
- heybooster — Heybooster is a provider of analytical tools to ecommerce companies to take better digital marketing decisions.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
b.value AG are into Biotechnology investments.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Chemical
- Stage:Seed, Series A
- Geography: Germany, Poland
Investor stats
- Total investments: 14
- Round size: Seed $478k–$2.5M; Series A $3M–$40M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results.
Show more...Investment focus
- Industry: FinTech, Apps, Social
- Stage:Series A, Series B, Post-IPO Equity
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 6
- Round size: Series A $45M–$157M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $1.3M–$7.5M; Series A $6M–$46M; Series B $15M–$226M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- ENOUGH — ENOUGH makes protein sustainable by producing ABUNDA mycoprotein, made by fermenting fungi with the natural sugars from grains. It is a whole protein with all 9 essential amino acids & rich in fibre. It is a B2B ingredient, neutral in taste and fibrous in texture, like meat. The most sustainable
- Change Bio — Change Bio converts waste methane into proteins to make them more affordable and carbon-negative.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 98
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
- Centauri Therapeutics — At Centauri we seek to tackle life-threatening infectious diseases in the most vulnerable patients.
Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $2M–$13M; Pre-Seed $665k–$4.3M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Ubitium — Ubiquitous computing, universal RISC-V microprocessor
- Nordic Air Defence — Nordic Air Defence builds cutting-edge solutions for modern aerial security. Made in Sweden.
- Fabric Cryptography — Fabric develops a custom cryptography hardware to accelerate cryptography algorithms. The chips, whose components exclusively serve cryptographic purposes, are based on Verifiable Processing Units (VPUs) which incorporate features of GPUs and ASICs to improve the speed and cost of advanced cryptographic workloads.
Holger Hübner
Show more...Investment focus
- Industry: B2B, SaaS, Audio
- Stage:Seed, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 5
- Round size: Seed $560k–$987k; Pre-Seed $177k–$329k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- musicube — MassiveMusic is a global music and sound partner specializing in sonic branding, sound strategy, music innovation & licensing.
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
- HorseAnalytics — HorseAnalytics empowers horse enthusiasts to monitor and improve health and training of horses by applying reliable technologies from health and sports supervision and combining constant and real-time scientific analytics.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 11
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 71
- Round size: Seed $1.6M–$17M; Series A $3.8M–$17M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $121M in 2022
Portfolio highlights
- DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
- Xperiome — Match research-ready members to clinical and real-world studies, faster and smarter than ever before through data-driven insights into the rare disease experience.
- AIRMO — Airmo is a space tech company that offers an independent data source that locates, quantifies, and tracks carbon dioxide and methane emissions through a small satellite constellation.
Michael E. Novogratz is based out of New York, New York, and is the Founder and CEO of Galaxy Digital. Michael previously served at Partner and President of Fortress Investment Group. Michael E. Novogratz attended Princeton University.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, FinTech
- Stage:Seed, Series A
- Geography: United States, India, Germany
Investor stats
- Total investments: 33
- Round size: Seed $953k–$8M; Series A $11M–$38M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
- CryptoQuant — CryptoQuant is a community-driven analytics platform to lower hurdles of data-based decisions. Crypto investors often fail to make data-based decisions due to a lack of time and knowledge. We lower the hurdles of data-based decisions by saving research time and decreasing the knowledge gap.
- Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
1kx is an early-stage investment firm focused on ecosystem growth.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 157
- Round size: Seed $1.8M–$11M; Series A $6M–$28M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Seam Social — Seam is a Pinterest-like social network where you post using user created miniapps.
- Giggles — Giggles is a social platform where users create and share content using artificial intelligence tools. The platform includes features for making short videos from prompts. Users can earn a digital currency called aura by engaging in activities and games. Digital assets are available for users to collect and trade. A waitlist is open for those whowant to join the platform.
- Impossible Cloud — Experience Impossible Cloud Storage: Secure, scalable, performant. Decentralized architecture, S3 API compatibility, 100% durability. Start free trial now.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 132
- Round size: Seed $2.3M–$13M; Series A $3.8M–$95M; Series B $8.8M–$80M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 44
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
- Aware — Aware is a mobile app for evaluating health data and for researching chronic diseases.
- Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Series A $5.5M–$19M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
Albert Wenger is a managing partner at Union Square Ventures. Before joining USV, Albert was the president of del.icio.us through the company’s sale to Yahoo and an angel investor (Etsy, Tumblr). He previously founded or co-founded several companies, including a management consulting firm and an early hosted data analytics company. Albert graduatedfrom Harvard College in economics and computer science and holds a Ph.D. in Information Technology from MIT.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 104
- Round size: Seed $650k–$13M; Series A $1M–$38M; Series B $4.3M–$30M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- DiviGas — DiviGas is an oil and gas company that developed a new process for manufacturing membranes which has yielded vastly superior results to what a membrane can do. The company was founded in 2019 and headquartered in Central Region, Singapore.
- Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
- Marvel Fusion — Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy. Its reactor is based on the short pulse, high energy, and electrically efficient laser that is suited for commercializing baseload fusion electrical power helping consumers to access clean, safe, and reliable energy sources.The company wasfounded in 2019 and is headquartered in Munich, Bayern.
Shine is an early-stage venture capital firm that partners with creative, convincing, relentless entrepreneurs to build iconic businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 68
- Round size: Seed $3.5M–$18M; Series A $12M–$25M; Series B $10M–$71M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Mentra — Mentra tackles systemic inequality by economically empowering underserved communities. We’re erasing the stigma around Disability Hiring with our recruiting platform that matches neurodiverse talent with inclusive employers.Our mission is to bring neurodiversity to the workplace - providing employers with thought diversity & job seekers witheconomic opportunity
- Rose Rocket — Rose Rocket's transportation management software (TMS) helps trucking companies and freight brokers improve visibility, collaboration, and efficiency.
- iVerify — IVerify is a mobile threat hunting company that provides mobile security solutions for individuals who want to know they can trust their devices with their most sensitive information without sacrificing privacy.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 212
- Round size: Seed $1M–$4.6M; Series A $2.2M–$9M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $33M in 2022
Portfolio highlights
- Jurafuchs — Jura lernen mit 50.000+ interaktiven Aufgaben, KI-Tutor & Spaced Repetition. Wissenschaftlich belegt: 1,8 Notenpunkte besser in 30 Tagen. Jetzt testen!
- Likeminded — Likeminded developed a digital platform for mental health that gives people fast, low-threshold access to psychological support.
- dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, Spain
Investor stats
- Total investments: 143
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- GermanSubCo — Vulcan Energie Ressourcen GmbH ("GermanSubCo") is the primary German holding subsidiary of Vulcan Energy Resources. It focused on lithium extraction combined with geothermal renewable energy production in the Upper Rhine Valley.
- Power Finance Corporation — Power Finance provides financial products and related advisory, and other services to the power sector in India. It offers fund based financial policies/products, including asset acquisition; bridge, corporate, short term, and rupee and foreign currency term loans; short term loan for SPV; buyer’s line of credit; and credit facility forpurchase of power. Power Finance's fund based financial policies/products also include debt refinancing; energy saving projects; fuel supply projects and equipment manufacturers financing; grants/interest free loans for studies/consultancies; lease financing for wind power projects and purchase of equipment; line of credit for import of coal; takeout financing; and solar PV policy to private sector. Its non-fund based products comprise guarantee, guarantee for credit enhancement, and letter of comfort. Power Finance also provides consultancy services in the areas of procurement of power by distribution licensees; renewable and non-conventional energy schemes; selection of developers for coal blocks; selection of EPC contractors; reform, restructuring, and regulatory aspects; capacity building and human resource development; and execution of ultra-mega power projects, and independent transmission projects. It serves state electricity boards, state power utilities, central power sector utilities, power departments, equipment manufacturers, private power sector utilities, joint sector power utilities, and other state departments engaged in the development of power projects. Power Finance began operation in 1986. It has its headquarters in New Delhi in India.
- Grenergy Renovables — Entwicklung von Photovoltaik und Speicher Projekten und Speicher Projekten mit Grenergy. Willkommen bei Grenergy
We invest in startups and VC funds that share our values across crucial sectors for the planet backed by a global network of entrepreneurs and scientists working towards a happier future
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, AgTech
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 29
- Round size: Seed $2M–$11M; Series A $10M–$46M; Series B $8.8M–$61M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- Innovacell — Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Totally supercool and chilled VC investing in programmable assets, collaborative intelligence and other buzzwords.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Information Technology
- Stage:Seed, Series A
- Geography: United States, Singapore, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $1.9M–$9M; Series A $2.8M–$43M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Biconomy — Blockchain transactions made simple. Enable Gasless meta-transactions, instant cross-chain transfers, easy layer 2 onboarding & zero failed transactions
- Ceramic Network — Ceramic Network is a provider of protocols for decentralized and composable data applications. The network decentralizes application databases, making data universally composable and reusable across applications. It consists of three core parts: a highly-scalable, decentralized infrastructure for data availability and consensus, a marketplace ofcommunity-created data models, and a suite of standard APIs for storing, updating, and retrieving data from those models.
- Pocket Universe — Pocket Universe is a browser extension that keeps your assets safe when you sign web3 transactions
EQT is an investment organization committed to creating value by finding good companies and helping them become the most promising builders of tomorrow.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Series A $46M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Lionheart Ventures is a global, seed-stage venture capital firm focused on mitigating civilizational risk. We do this by supporting the wise development of transformative technologies. Our main areas of investment focus are transformative artificial intelligence and frontier mental health technologies.Leading academics estimate a 1-in-6 chance ofhuman extinction by the year 2100, largely driven by risks from emerging technologies. And now, with the exponential growth of AI, predictions are getting worse. Our startups are part of the solution. We invest in exceptional, ethical founders who are developing transformative technologies that have the potential to impact humanity on a meaningful scale, while generating attractive returns for our LPs.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 39
- Round size: Seed $1.6M–$11M; Series A $25k–$46M
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Piramidal — Piramidal offers artificial intelligence software that transforms brain activity into easy-to-understand health data to help diagnose neurological diseases.
- Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investitionsbank Berlin (IBB) is the subsidy bank of the Federal Land of Berlin. With its newly orientated economic support and subsidy policy, it actively contributes towards developing Berlin as a business and industry location.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Grant, Seed
- Geography: Germany, Canada
Investor stats
- Total investments: 57
- Round size: Seed $598k–$2.3M; Grant $19k–$1.4M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Quantune — Quantune is a deep tech startup in optics and photonics technology. It develops laser spectrometer for continuous and non-invasive health monitoring.
- CyberTide — CyberTide is an AI-based Data Leak Prevention Solution
- muffintech — Generative AI for the insurance industry. Unleash the full potential of your employees and offer your customers an unmatched user experience.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 170
- Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
- Biolinq — Introducing a revolutionary platform for metabolic health.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.
Show more...Investment focus
- Industry: Big Data, TV, B2B
- Stage:Seed, Series A, Series C
- Geography: United Kingdom, Germany
Investor stats
- Total investments: 6
- Round size: Series A $26M–$26M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Olvin — Menara188 ialah situs yang di jamin amanah dengan layanan super aman di jamin terpercaya resmi , ewallet digital hanya depo 5k sudah bisa bermain disini.
- DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
- AtaiBeckley — We are a clinical-stage biopharmaceutical company developing new mental health treatments to transform patient outcomes.
Nico Wittenborn is an Investor at Adjacent.
Show more...Investment focus
- Industry: Software, Apps, Wellness
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, France
Investor stats
- Total investments: 42
- Round size: Seed $1.6M–$8.5M; Series A $7.1M–$30M; Series B $7.5M–$88M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Niantic — Niantic’s mission is to use emerging technology to enrich our experiences as human beings in the physical world. We seek to build products that inspire movement, exploration, and face-to-face social interaction. Originally formed at Google in 2010, we are now an independent company with a strong group of investors including Nintendo, The PokémonCompany, and Alsop Louie Partners. We’re focused on building games that get people outside and exploring by enabling our players to have fun while visiting new places, learning about the world around them, and meeting new friends. We’ve launched Ingress, an immersive real-world mobile game played by millions of people; it's been downloaded more than 20 million times and is played in over 200 countries and territories worldwide. We've also developed Pokémon GO, which has broken records around the world and has been downloaded more than 750 million times in its first year.
- Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
- Sunnyside — Sunnyside is the #1 alcohol moderation app helping 600,000+ people drink less through tracking, coaching, and optional naltrexone via telehealth. Start your free 15-day trial.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 93
- Round size: Series A $2M–$12M; Series B $5.1M–$20M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $94M in 2016
Portfolio highlights
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
KdT Ventures is the standard for early-stage frontier science investing.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, Germany
Investor stats
- Total investments: 77
- Lead/follow: no public data
Portfolio highlights
- Marigold Health — Marigold Health is an anonymous social network where people with mental health and substance use conditions support each other.
- Radar Therapeutics — Precision-targeted, smart therapies to conquer the world's most intractable diseases.
- Montara Therapeutics — Montara Therapeutics is a precision-medicine neuroscience biotech startup improving safety and efficacy of therapies for people with neurological diseases
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Spain
Investor stats
- Total investments: 26
- Lead/follow: no public data
Portfolio highlights
- IonKraft — IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
- Eeden — Eeden engages in the manufacture and supply of textiles.
- PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
NAP is a Berlin-based pre-seed and seed venture capital investor, investing in European technology companies. NAP backs founders who turn non-obvious ideas into realities. The team includes former operators and builders with extensive experience in scaling companies. NAP supports its portfolio companies through capital, guidance, and connections.NAP’s key portfolio highlights include Aleph Alpha, Ampeco, Flip, PlanRadar, Spread, and Usercentrics.
Show more...Investment focus
- Industry: Software, Health Care, Life Science
- Stage:Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- VoiceLine — VoiceLine is AI-powered field sales revenue intelligence. Document any customer interactions in seconds, get actionable insights and boost sales performance. Start today!
- beSirius — beSirius transforms ESG chaos into clarity - connecting your data to spot trends, reveal revenue signals, and answer any stakeholder in minutes. Smarter decisions, faster deals, zero admin drain.
Boost VC: The Pre-Seed Fund Making Sci-FI a Reality. Investing in crypto, virtual reality, augmented reality, AI, Ocean Tech, Space Tech, human augmentation, exoskeletons and more.
Show more...Investment focus
- Industry: Software, Virtual Reality, Blockchain
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 212
- Lead/follow: no public data
Portfolio highlights
- forml — Use forml to build and integrate intelligent workflows for any task in seconds, with flexible integrations.
- ego AI — Building intelligent, embodied characters that bring human-like behavior to games, simulations, and beyond.
- Neurvona — AI Digital Twin Personas
Till Knorr
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Belyntic — Difficulties in peptide manufacturing? Our advanced peptide technology platform enables you to generate even the most difficult sequences with seemless choice in throughput and scale. We offer the worlds's first broadly applicable purification kits without the need for costly instrumentation. Check out the ultimate tool for your peptideworkflows and possibilities to develop most efficient peptide drugs.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Indiana Capital is a team of private equity and venture capitalists that offer funding and assist businesses from setup to operations.
Show more...Investment focus
- Industry: News, Life Science, Social Media
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Nikolaus Sturm
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
The German Federal Ministry of Education and Research funds research programs and institutions, supervises nuclear energy, and establishes educational policy in general.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Grant, Seed, Series B
- Geography: Germany, United States, Denmark
Investor stats
- Total investments: 58
- Lead/follow: no public data
Portfolio highlights
- NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
- CyberTide — CyberTide is an AI-based Data Leak Prevention Solution
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Boom Capital is a pre-seed fund for deeply technical, under-networked founders trying to build their companies. It was incorporated in 2017 and is based in San Francisco, California.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
- Waypoint Bio — Waypoint's proprietary spatial multi-omics platform enables us to solve critical issues around understanding how cell therapies navigate the three-dimensional tumor microenvironment and allow the measurement of cell-to-cell interactions.
Acurio Ventures partners with visionary founders to make history happen. Acurio Ventures is a European early-stage VC that invests across sectors and business models and that relies on its entrepreneurial DNA, flexible approach and proven value add to partner with the best founders out there.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A, Series B
- Geography: Spain, United States, Germany
Investor stats
- Total investments: 109
- Lead/follow: no public data
Portfolio highlights
- Flagcat — Paris-based webtoon studio producing ambitious series and commited to improve artists' working conditions through cutting-edge technology developments
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- ai|coustics — ai|coustics is pioneering innovative audio algorithms based on AI and Deep Learning models and fundamentally improving the capabilities of Speech Audio Enhancement in digital communication and media content.
Dit is de Kitchensink.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Health Care
- Stage:Seed, Series A
- Geography: The Netherlands, Germany
Investor stats
- Total investments: 17
- Lead/follow: no public data
Portfolio highlights
- Circularise — Circularise brings transparency to global supply chains. Circularise offers different solutions for different problems within the supply chain. Learn how you can become part of the Circular Economy and what solution Circularise can offer your company.
- Corporis Medical — Corporis Medical is a start up focussing on the development and commercialization of innovative medical devices that improve outcomes of surgical interventions. Formerly known as Health Value Creation.
- ReSolved Technologies — ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Seed, Series B
- Geography: Germany, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Actome — Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.
- Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
- Coley Pharmaceutical Group — Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changedits name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.
An international, Swiss-based family office, focusing on private equity (venture & buy-out), real estate and listed assets.
Show more...Investment focus
- Industry: Health Care, Biotechnology, SaaS
- Stage:Seed, Series A, Series C
- Geography: Germany, Switzerland, France
Investor stats
- Total investments: 31
- Lead/follow: no public data
Portfolio highlights
- Supervizor — Supervizor allows companies to automatically check all accounting and operational data, and detect errors and fraud. No setup or dry runs required.
- StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
- SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.
Teknoloji Yatırım is the first actor investing in early-stage technology companies in Turkey. Aiming at preparing the venture capital ecosystem for new players, Teknoloji Yatırım designs, develops and manages innovative tools to meet the financing needs of technology companies in the early and growth stages. What We Do: - Direct Investments: Wemake equity investments to technology companies having internationalization potential. - Co-Investments and Follow-on Investments: We make co-investments and follow-on investments to technology companies at scaling and growth stages, together with other Venture Capital Funds. - Consultancy Services: We offer consultancy solutions in the design, implementation and management of innovative investment tools and models.
Show more...Investment focus
- Industry: Software, Machine Learning, Analytics
- Stage:Seed, Series A, Convertible Note
- Geography: Turkey, United States, Germany
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- Cellsway — Cellsway is a liquid biopsy company that was created to provide quick cancer CTC detection methods. The business's technology, which is minimally invasive and uses a straightforward blood sample for cancer monitoring, enables healthcare professionals to heal their patients and enhance their quality of life. focuses on the development ofmicrofluidics and lab-on-a-chip technologies for biomedical purposes.
- BRANDEFENSE — Brandefense platform is a proactive digital risk protection solution for organizations. Our AI-driven technology constantly scans the dark, deep, and surface web.
- Mindsite — Mindsite provides e-commerce analytics. Easily monitor key metrics from price to visibility in real time. Increase your online sales.
Pillar VC is a pre-seed and seed venture capital firm that invests in technical breakthroughs and exceptional founders.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: United States, Spain, Israel
Investor stats
- Total investments: 147
- Lead/follow: no public data
Portfolio highlights
- Acelab — Discover and compare over 25,000 building products with Acelab. Find the best solutions for your construction projects. Explore our catalog today.
- Tycho AI — Tycho AI delivers autonomous intelligence with AI that acts independently, adapts in real time, and drives mission outcomes at the edge.
- Addis Energy — Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production.
Life Science Investor funding in Germany at a glance
Stats across 131 deals from 250 investors.
Access all 250 investors in Germany Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 250 investors investing in Germany Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!